Adverum Biotechnologies, Inc

(NASDAQ:ADVM)

Latest On Adverum Biotechnologies, Inc (ADVM):

Date/Time Type Description Signal Details
2023-05-12 05:45 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.29N/A
2023-03-31 16:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.33 beats by $0.03N/A
2022-11-11 05:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.40 misses by $0.06N/A
2022-08-11 22:16 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.44 misses by $0.10N/A
2022-07-08 00:31 ESTNewsAdverum gains 13% to reach three-month high after Truist upgradeN/A
2022-06-10 10:03 ESTNewsAdverum wet AMD candidate ADVM-022 shows long-term benefit after single injectionN/A
2022-05-13 06:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.38 misses by $0.07N/A
2022-04-07 03:30 ESTNewsAdverum gets FDA feedback on mid-stage trial for Wet AMD candidateN/A
2022-03-29 21:15 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.35 misses by $0.01N/A
2022-02-07 17:00 ESTNewsAdverum Biotechnologies names new CMON/A
2022-01-03 15:46 ESTNewsAdverum granted FDA’s Orphan Drug Designation for treatment targeting color blindnessN/A
2021-11-05 00:15 ESTNewsAdverum Biotechnologies EPS misses by $0.01N/A
2021-10-02 05:31 ESTNewsAdverum posts promising two-year data for one-time injection in Wet AMDN/A
2021-10-02 05:31 ESTNewsADVM, SCPS, HX and NUVL among after hours moversN/A
2021-08-05 21:02 ESTNewsAdverum Biotechnologies EPS misses by $0.07N/A
2021-07-23 14:16 ESTNewsAdverum plunges as analysts turn bearish citing setback for diabetic macular edema drugN/A
2021-07-22 18:17 ESTNewsAdverum scraps development plans for ADVM-022 to treat diabetic macular edemaN/A
2021-07-20 17:43 ESTNewsAdverum President/CFO resigns, replacement namedN/A
2021-05-07 02:46 ESTNewsAdverum Biotechnologies EPS beats by $0.09, beats on revenueN/A
2021-05-06 06:34 ESTNewsAdverum Biotechnologies: An Uncertain Path ForwardN/A
2021-05-03 17:04 ESTNewsAdverum Bio presents long-term data from ADVM-022 trial in wet AMDN/A
2021-05-03 17:04 ESTNewsAdverum Biotechnologies: One Adverse Event Too ManyN/A
2021-05-03 17:03 ESTNewsTenet reinstated buy at Goldman Sachs, Adverum downgraded; in today’s healthcare analyst actionN/A
2021-04-30 05:05 ESTNewsAs Adverum plunges 62%, major shareholder calls for board changes (updated)N/A
2021-04-29 06:17 ESTNewsAdverum Biotechnologies provides update on ADVM-022 diabetic macular edema trialN/A
2021-03-26 04:01 ESTNewsAdverum Biotechnologies perks up after insider buyingN/A
2021-03-08 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25 to $24.89.Neutral
2021-03-04 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.25 to $25.Neutral
2021-03-03 21:16 ESTNewsAdverum Biotechnologies, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-03-03 15:02 ESTEarnings EstimateAn EPS average of -$1.82 is estimated for the 2022 year.Sell
2021-03-03 15:02 ESTEarnings EstimateAn EPS average of -$0.38 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-03 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.88 to $25.25.Neutral
2021-03-02 23:02 ESTFinancialsCompany financials have been released.Neutral
2021-03-02 07:16 ESTNewsAdverum Biotechnologies EPS misses by $0.06N/A
2021-03-02 07:16 ESTNewsAdverum Biotechnologies, Inc's (ADVM) CEO Laurent Fischer on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-19 04:46 ESTNewsAdverum Biotechnologies names new business chiefN/A
2021-02-12 11:02 ESTAnalyst RatingThe Analyst Target Price has increased from $25.22 to $25.88.Buy
2021-02-02 21:02 ESTNewsAdverum highlights preclinical long-term safety data on ADVM-022 IVT gene therapyN/A
2021-01-21 05:17 ESTNewsAdverum jumps 16% after insider transactionsN/A
2021-01-11 00:01 ESTNewsAdverum In Wet AMD And Diabetic Macular Edema: Playing In A Differentiated MarketN/A
2021-01-07 22:16 ESTNewsAdverum to invest $80M in new gene therapy manufacturing facilityN/A
2020-12-29 11:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $26.75 to $25.22.Neutral
2020-12-13 03:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-16 15:01 ESTNewsAdverum ticks lower on underwhelming data from gene therapy in wet-AMDN/A
2020-11-10 19:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $27 to $26.75.Neutral
2020-11-09 03:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 23:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $27.38 to $27.Neutral
2020-11-06 11:02 ESTEarnings EstimateAn EPS average of -$0.36 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 01:16 ESTNewsAdverum Biotechnologies EPS beats by $0.04N/A

About Adverum Biotechnologies, Inc (ADVM):

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

ADVM Quotes by TradingView

See Advanced Chart

General

  • Name Adverum Biotechnologies, Inc
  • Symbol ADVM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 167
  • Fiscal Year EndDecember
  • IPO Date2014-07-31
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.adverum.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3419.85
  • Price/Book (Most Recent Quarter) 2.73
  • Enterprise Value Revenue 3700.64
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.68
  • Next Year EPS Estimate -$2.00
  • Next Quarter EPS Estimate -$0.31
  • Return on Assets -21%
  • Return on Equity -39%
  • Earnings Per Share -$1.05
  • Revenue Per Share $0
  • Gross Profit -73309000
  • Quarterly Earnings Growth -70%
View More

Highlights

  • Market Capitalization 1.01 billion
  • EBITDA -59744000
  • Analyst Target Price $24.89
  • Book Value Per Share $4.45
View More

Share Statistics

  • Shares Outstanding 97.8 million
  • Shares Float 61.93 million
  • % Held by Insiders 75%
  • % Held by Institutions 96.25%
  • Shares Short 10.05 million
  • Shares Short Prior Month 9.46 million
  • Short Ratio 14.75
  • Short % of Float 11%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.49
  • 52 Week High $26.98
  • 52 Week Low $8.27
  • 50 Day Moving Average 12.45
  • 200 Day Moving Average 12.28
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Adverum Biotechnologies, Inc (ADVM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Adverum Biotechnologies, Inc (ADVM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.39-$0.33-18.51%
2020-09-302020-11-05$N/A-$0.31-$0.3511.43%
2020-06-302020-08-10$N/A-$0.36-$0.29-23.58%
2020-03-312020-05-28$N/A-$0.31-$0.27-14.35%
2019-12-312020-03-12$N/A-$0.29-$0.302.26%
2019-09-302019-11-07$250000-$0.25-$0.265.41%
2019-06-302019-08-08$N/A-$0.23-$0.2713.21%
2019-03-312019-05-08$N/A-$0.23-$0.2714.18%
2018-12-312019-03-06$70000-$0.25-$0.2912.59%
2018-09-302018-11-08$833000-$0.34-$0.30-13.98%
2018-06-302018-08-08$493000-$0.30-$0.312.18%
2018-03-312018-05-09$216000-$0.30-$0.29-3.45%
2017-12-312018-03-06$461000-$0.32-$0.346.79%
2017-09-302017-11-08$463000-$0.32-$0.29-10.34%
2017-06-302017-08-08$463000-$0.27-$0.3316.92%
2017-03-312017-05-09$462000-$0.38-$0.26-46.15%
2016-12-312017-03-06$488000-$0.54-$0.30-78.04%
2016-09-302016-11-08$395000-$0.35-$0.29-19.33%
2016-06-302016-08-09$307000-$1.76-$0.33-441.54%
2016-03-312016-05-06$265000-$0.57-$0.29-96.55%
2015-12-312016-03-03$960000-$0.55-$0.40-36.37%
2015-09-302015-11-09$953000-$0.55-$0.42-30.95%
2015-06-302015-08-13$203000-$0.38-$0.392.56%
2015-03-312015-05-13$203000-$0.38-$0.405%
2014-12-312015-03-05$203000-$0.46-$0.29-58.62%
2014-09-302014-11-12$204000-$0.50-$0.21-138.1%
2014-06-302014-09-11$135000-$2.27

Adverum Biotechnologies, Inc (ADVM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Adverum Biotechnologies, Inc (ADVM) Chart:

Adverum Biotechnologies, Inc (ADVM) News:

Below you will find a list of latest news for Adverum Biotechnologies, Inc (ADVM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Adverum Biotechnologies, Inc (ADVM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-10-1713.97CALL0 41386.56TRUE00
2025-10-1720CALL0 0239.07TRUE00
2025-10-1732.48CALL0 21346.19TRUE00
2025-10-1741.67CALL0 71165.43TRUE00
2025-10-1750.65CALL0 127115.07TRUE00
2025-10-1760.33CALL5 78136.32FALSE-0.02-0.06
2025-10-1770.2CALL0 7257.49FALSE00
2025-10-1780CALL0 0280.01FALSE00
2025-10-1710PUT0 00FALSE00
2025-10-1720.05PUT0 25866.78FALSE00
2025-10-1730.02PUT1 622175.3FALSE-0.03-0.6
2025-10-1740.23PUT0 67185.42FALSE00
2025-10-1751.05PUT0 8201.44FALSE00
2025-10-1762.25PUT0 2203.44TRUE00
2025-10-1770PUT0 0217.73TRUE00
2025-10-1780PUT0 0194.99TRUE00
2025-11-2110CALL0 00TRUE00
2025-11-2120CALL0 0174.38TRUE00
2025-11-2131.58CALL0 4130.24TRUE00
2025-11-2141CALL0 10184.17TRUE00
2025-11-2150.85CALL0 5159.66TRUE00
2025-11-2160.75CALL0 10150.09FALSE00
2025-11-2170.5CALL0 11178.83FALSE00
2025-11-2180CALL0 0269.92FALSE00
2025-11-2110PUT0 00FALSE00
2025-11-2120PUT0 00FALSE00
2025-11-2130.05PUT0 1205.67FALSE00
2025-11-2140PUT0 0177.3FALSE00
2025-11-2150.7PUT0 20154.8FALSE00
2025-11-2162.3PUT0 0165.48TRUE00
2025-11-2170PUT0 0175.35TRUE00
2025-11-2180PUT0 0118.22TRUE00
2025-12-1910CALL0 0337.22TRUE00
2025-12-1923.5CALL0 1337.78TRUE00
2025-12-1931.45CALL0 95122.06TRUE00
2025-12-1941.75CALL9 112102.18TRUE0.050.03
2025-12-1950.65CALL0 4142.97TRUE00
2025-12-1960.69CALL0 13110.98FALSE00
2025-12-1970.3CALL0 171151.78FALSE00
2025-12-1980CALL0 0157.76FALSE00
2025-12-1910PUT0 0689.43FALSE00
2025-12-1920.02PUT0 58434.36FALSE00
2025-12-1930.5PUT0 62164.03FALSE00
2025-12-1940.61PUT0 1104148.57FALSE00
2025-12-1951.2PUT0 20140.69FALSE00
2025-12-1961.95PUT0 20163.76TRUE00
2025-12-1970PUT0 0109.63TRUE00
2025-12-1980PUT0 0105.28TRUE00
2026-03-2010CALL0 0244.71TRUE00
2026-03-2022.77CALL0 2168.96TRUE00
2026-03-2032.9CALL0 45132.69TRUE00
2026-03-2042.21CALL21 325111.25TRUE2.210
2026-03-2051.85CALL3 365118.16TRUE0.10.06
2026-03-2060.85CALL0 4142.83FALSE00
2026-03-2071CALL0 170123.69FALSE00
2026-03-2080.95CALL0 12103.69FALSE00
2026-03-2010.32PUT0 400FALSE00
2026-03-2020PUT0 0226.02FALSE00
2026-03-2030.95PUT0 20163.27FALSE00
2026-03-2041.18PUT0 150153.7FALSE00
2026-03-2051.33PUT0 261119.92FALSE00
2026-03-2060PUT0 0116.3TRUE00
2026-03-2073.04PUT0 20120.04TRUE00
2026-03-2080PUT0 0123.28TRUE00

Latest ADVM Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST800$0.952
Jun 13, 2022 7:58 PM EST100$0.952
Jun 13, 2022 7:59 PM EST13$0.951
Jun 13, 2022 7:59 PM EST8$0.951
Jun 13, 2022 7:59 PM EST33$0.951

Adverum Biotechnologies, Inc (ADVM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520182655/0001193125-20-182655-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000021545719006772/0000215457-19-006772-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000083423720004851/0000834237-20-004851-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419000919/0000902664-19-000919-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419001088/0000902664-19-001088-index.htm
2019-05-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419002558/0000902664-19-002558-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266420000939/0000902664-20-000939-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266420001119/0000902664-20-001119-index.htm
2019-03-21SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359419000276/0001013594-19-000276-index.htm
2019-05-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359419000364/0001013594-19-000364-index.htm
2020-08-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359420000655/0001013594-20-000655-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000103738919000142/0001037389-19-000142-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000103738920000303/0001037389-20-000303-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000117266120000647/0001172661-20-000647-index.htm
2018-03-23S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312518094349/0001193125-18-094349-index.htm
2018-04-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312518124872/0001193125-18-124872-index.htm
2018-04-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312518124877/0001193125-18-124877-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518150878/0001193125-18-150878-index.htm
2018-05-09DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312518157646/0001193125-18-157646-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518181838/0001193125-18-181838-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518194580/0001193125-18-194580-index.htm
2018-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518211393/0001193125-18-211393-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518301082/0001193125-18-301082-index.htm
2018-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518306392/0001193125-18-306392-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519060892/0001193125-19-060892-index.htm
2019-03-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519067443/0001193125-19-067443-index.htm
2019-03-12S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519071950/0001193125-19-071950-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519117153/0001193125-19-117153-index.htm
2019-04-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000119312519126512/0001193125-19-126512-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519135105/0001193125-19-135105-index.htm
2019-06-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519174714/0001193125-19-174714-index.htm
2019-06-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312519174720/0001193125-19-174720-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519208871/0001193125-19-208871-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519210860/0001193125-19-210860-index.htm
2019-08-08S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1501756/000119312519216895/0001193125-19-216895-index.htm
2019-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519216899/0001193125-19-216899-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519240084/0001193125-19-240084-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519243345/0001193125-19-243345-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519314138/0001193125-19-314138-index.htm
2020-02-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520029953/0001193125-20-029953-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520033298/0001193125-20-033298-index.htm
2020-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520033345/0001193125-20-033345-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520071731/0001193125-20-071731-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520112176/0001193125-20-112176-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520123125/0001193125-20-123125-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312520123159/0001193125-20-123159-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520169353/0001193125-20-169353-index.htm
2020-06-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312520174007/0001193125-20-174007-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520182655/0001193125-20-182655-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520215063/0001193125-20-215063-index.htm
2020-08-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520216586/0001193125-20-216586-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520219223/0001193125-20-219223-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520219248/0001193125-20-219248-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038052/0001209191-18-038052-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038054/0001209191-18-038054-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038055/0001209191-18-038055-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038058/0001209191-18-038058-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038066/0001209191-18-038066-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038086/0001209191-18-038086-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038333/0001209191-18-038333-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038335/0001209191-18-038335-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038336/0001209191-18-038336-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118055834/0001209191-18-055834-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011063/0001209191-19-011063-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011066/0001209191-19-011066-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011069/0001209191-19-011069-index.htm
2019-04-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119022581/0001209191-19-022581-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119022603/0001209191-19-022603-index.htm
2019-04-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119026003/0001209191-19-026003-index.htm
2019-04-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119026004/0001209191-19-026004-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027386/0001209191-19-027386-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027389/0001209191-19-027389-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027391/0001209191-19-027391-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027395/0001209191-19-027395-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027396/0001209191-19-027396-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027398/0001209191-19-027398-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027832/0001209191-19-027832-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044245/0001209191-19-044245-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044247/0001209191-19-044247-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044249/0001209191-19-044249-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044251/0001209191-19-044251-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044254/0001209191-19-044254-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044256/0001209191-19-044256-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044258/0001209191-19-044258-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044260/0001209191-19-044260-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046306/0001209191-19-046306-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046311/0001209191-19-046311-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046313/0001209191-19-046313-index.htm
2019-10-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054092/0001209191-19-054092-index.htm
2019-11-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054741/0001209191-19-054741-index.htm
2019-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054742/0001209191-19-054742-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119061950/0001209191-19-061950-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120001014/0001209191-20-001014-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007754/0001209191-20-007754-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007755/0001209191-20-007755-index.htm
2020-02-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007756/0001209191-20-007756-index.htm
2020-02-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007757/0001209191-20-007757-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007758/0001209191-20-007758-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007759/0001209191-20-007759-index.htm
2020-02-144/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009846/0001209191-20-009846-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009848/0001209191-20-009848-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011783/0001209191-20-011783-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011785/0001209191-20-011785-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011787/0001209191-20-011787-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011789/0001209191-20-011789-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120012797/0001209191-20-012797-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120012798/0001209191-20-012798-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120020107/0001209191-20-020107-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2020-04-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120025153/0001209191-20-025153-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120025154/0001209191-20-025154-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120027287/0001209191-20-027287-index.htm
2020-05-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120028067/0001209191-20-028067-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-05-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031045/0001209191-20-031045-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037330/0001209191-20-037330-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037335/0001209191-20-037335-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037369/0001209191-20-037369-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038958/0001209191-20-038958-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038959/0001209191-20-038959-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038960/0001209191-20-038960-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038962/0001209191-20-038962-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038963/0001209191-20-038963-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038964/0001209191-20-038964-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038966/0001209191-20-038966-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038967/0001209191-20-038967-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120047622/0001209191-20-047622-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120047624/0001209191-20-047624-index.htm
2018-11-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315218016327/0001493152-18-016327-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315219001941/0001493152-19-001941-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315220002379/0001493152-20-002379-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018012437/0001564590-18-012437-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018020510/0001564590-18-020510-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018028654/0001564590-18-028654-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000156459019006536/0001564590-19-006536-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019017203/0001564590-19-017203-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019030765/0001564590-19-030765-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019041787/0001564590-19-041787-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000156459020010503/0001564590-20-010503-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020007251/0001628280-20-007251-index.htm
2020-05-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020008534/0001628280-20-008534-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020012330/0001628280-20-012330-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/0001628280-20-012332-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020015738/0001628280-20-015738-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020015761/0001628280-20-015761-index.htm
2018-04-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999718004871/9999999997-18-004871-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999719001422/9999999997-19-001422-index.htm
2020-06-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999720003738/9999999997-20-003738-index.htm

Adverum Biotechnologies, Inc (ADVM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adverum Biotechnologies, Inc (ADVM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 75%
Institutional Ownership: 9625%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-17Peter SoparkarChief Legal OfficerBuy7,692.0013.0099,996.0010,692.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120047624/0001209191-20-047624-index.htm
2020-06-16LEONE D PATTERSONPresidentSell13,171.0024.68325,060.28110,488.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037369/0001209191-20-037369-index.htm
2018-06-15Jennifer C. ChengGeneral CounselBuy11,150.00118,863.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038335/0001209191-18-038335-index.htm
2020-03-20LEONE D PATTERSONCEO, President and DirectorSell39,526.0010.17401,908.27123,429.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2020-05-06LEONE D PATTERSONCEO, President and DirectorSell20,000.0020.02400,400.00123,659.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-03-17LEONE D PATTERSONCEO, President and DirectorSell474.0010.024,749.24138,531.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120020107/0001209191-20-020107-index.htm
2020-05-06LEONE D PATTERSONCEO, President and DirectorBuy20,000.003.4468,800.00143,659.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-03-20LEONE D PATTERSONCEO, President and DirectorBuy24,424.003.4484,018.56162,955.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2019-05-06James Paul ScopaDirectorBuy20,000.006.71134,200.0020,000.00https://www.sec.gov/Archives/edgar/data/1501756/000120919119027832/0001209191-19-027832-index.htm
2019-12-23LEONE D PATTERSONCEO, President and DirectorSell40,000.0010.72428,800.00228,496.00https://www.sec.gov/Archives/edgar/data/1501756/000120919119061950/0001209191-19-061950-index.htm
2020-02-12Mehdi GasmiDirectorSell10,000.0015.07150,690.00258,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-02-18Mehdi GasmiDirectorSell5,000.0016.2381,156.00258,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2020-02-18Mehdi GasmiDirectorBuy5,000.004.8024,000.00263,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2018-06-15LEONE D PATTERSONSVP, CFO, Interim Pres and CEOBuy88,496.00268,496.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038333/0001209191-18-038333-index.htm
2020-02-12Mehdi GasmiDirectorBuy10,000.004.8048,000.00268,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-05-05Mehdi GasmiDirectorSell10,000.0016.26162,573.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-06Mehdi GasmiDirectorSell25,000.0020.03500,667.50274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-18Mehdi GasmiDirectorSell300.0019.035,709.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-20Mehdi GasmiDirectorSell1,401.0020.0128,029.95274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-05-21Mehdi GasmiDirectorSell3,599.0020.0272,048.02274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-15Mehdi GasmiDirectorSell159.0023.593,751.18274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-17Mehdi GasmiDirectorSell268.0025.016,702.71274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-18Mehdi GasmiDirectorSell11,127.0025.01278,328.55274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-22Mehdi GasmiDirectorSell23,605.0025.06591,616.84274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-07-20Mehdi GasmiDirectorSell5,000.0017.6087,978.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-06-15Mehdi GasmiDirectorSell3,425.0023.0078,786.65274,601.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-17Mehdi GasmiDirectorBuy268.004.801,286.40274,710.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-05-18Mehdi GasmiDirectorSell4,700.0018.1185,124.05274,742.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-20Mehdi GasmiDirectorBuy1,401.004.806,724.80275,843.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-15Mehdi GasmiDirectorSell1,416.0021.9331,047.07278,026.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-05-21Mehdi GasmiDirectorBuy3,599.004.8017,275.20278,041.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-05-18Mehdi GasmiDirectorBuy5,000.004.8024,000.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-07-20Mehdi GasmiDirectorBuy5,000.004.8024,000.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-06-15Mehdi GasmiDirectorSell5,000.0021.01105,042.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-05-05Mehdi GasmiDirectorBuy10,000.004.8048,000.00284,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-06-15Mehdi GasmiDirectorBuy10,000.004.8048,000.00284,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-18Mehdi GasmiDirectorBuy11,127.004.8053,409.60285,569.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-22Mehdi GasmiDirectorBuy23,605.004.80113,304.00298,047.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-05-06Mehdi GasmiDirectorBuy25,000.004.80120,000.00299,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-02-14James Paul ScopaDirectorBuy10,000.0013.75137,500.0030,000.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009848/0001209191-20-009848-index.htm
2020-01-15Mehdi GasmiDirectorBuy88,496.00321,418.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2018-06-15Mehdi GasmiChief Science & Tech OfficerBuy88,496.00387,031.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038336/0001209191-18-038336-index.htm
2020-05-04James Paul ScopaDirectorBuy23,334.006.48151,204.3253,334.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120027287/0001209191-20-027287-index.htm
2020-08-17Laurent FischerCEO and DirectorBuy7,692.0013.0099,996.007,692.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120047622/0001209191-20-047622-index.htm